Geng et al. reported that insulin-like growth factor-2 mRNA-binding protein 3 (IGF2BP3) and YTHDC2 were differentially expressed in patients with RA and controls, which had a high diagnostic value [19]. The gene discussed is IGF2BP3; the disease is rheumatoid arthritis.